PT - JOURNAL ARTICLE AU - Bourque, Gabrielle AU - Ilin, Julius Vladimir AU - Ruzicka, Marcel AU - Davis, Alexandra AU - Hundemer, Gregory AU - Hiremath, Swapnil TI - The Prevalence of Non-Adherence in Patients with Resistant Hypertension: a Systematic Review and Meta-Analysis AID - 10.1101/2020.08.14.20175125 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.14.20175125 4099 - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20175125.short 4100 - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20175125.full AB - Background Resistant hypertension is quite prevalent and a risk factor for cardiovascular events. Patients with suspected resistant hypertension undergo more screening intensity for secondary hypertension, despite some of them being non-adherent to prescribed pharmacotherapy. The prevalence of non-adherence in this setting varies from about 5 to 80% in the published literature. Apart from the wide range, the relation between method of assessment and prevalence is not well established. Our objective was to establish the overall prevalence of non-adherence in the apparent treatment resistant hypertension population, explore causes of heterogeneity, and evaluate the effect of the method of assessment on the estimate of non-adherence.Methods We performed a systematic review and meta-analysis. MEDLINE, EMBASE Classic+EMBASE, Cochrane, CINAHL, and Web of Science were searched for relevant articles. Details about the method of adherence assessment were extracted from each included article and grouped into direct and indirect. Pooled analysis was performed using the random effects model and heterogeneity was explored with metaregression and subgroup analyses.Results The literature search yielded 1428 studies, of which 36 were included. The pooled prevalence of non-adherence was 35% (95% confidence interval 25 – 46 %). For indirect methods of adherence assessment, it was 25% (95% CI 15 – 39 %), whereas for direct methods of assessment, it was 44% (95% CI 32 – 57 %). Metaregression suggested gender, age, and time of publication as potential factors contributing to the heterogeneity.Conclusions Non-adherence to pharmacotherapy is quite common in resistant hypertension, with the prevalence varying with the methods of assessment.Brief Summary Resistant hypertension is known to be a risk factor for cardiovascular events. These patients also undergo higher screening intensity for secondary hypertension. However, not all patients with apparent treatment resistant hypertension have true resistant hypertension, with some of them being non-adherent to prescribed pharmacotherapy. This systematic review aims to establish the overall prevalence of non-adherence in the apparent treatment resistant hypertension population and assess the relative contributions of non-adherence assessed with direct and indirect measures.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCRD42020137944Funding StatementNo direct fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Systematic Review, no IRB approval necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe only use publicly available dataABPMAmbulatory Blood Pressure MonitoringBPBlood PressureCHFCongestive Heart FailureCIConfidence IntervalCINHALCumulative Index of Nursing and Allied Health LiteratureCKDChronic Kidney DiseaseCVDCerebrovascular DiseaseDBPDiastolic Blood PressureDOTDirectly Observed TherapyHRHeart RateMARSMedication Adherence Report ScaleMEMSMedication Event Monitoring SystemMMASMorisky Medication Adherence ScalePDCProportion of Days CoveredPRISMAPreferred Reporting Items for Systematic Reviews and Meta-AnalysesRCTsRandomized Controlled TrialsRHResistant HypertensionSBPSystolic Blood PressureTDMTherapeutic Drug Monitoring